March 24, 2025 · Form 4 insider transaction
Wettig Thane bought 145,000 shares of FibroGen Incorporated at $0.35 per share, a transaction worth $50.7K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.34 to $0.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.